4/2
Coronavirus Research
Hydroxychloroquine no more effective than placebo in preventing COVID-19
A Penn clinical trial shows health care workers in contact with COVID-19 patients who took hydroxychloroquine daily did not reduce their rate of infection.
Adolescents, psychiatric hospitalization, and COVID-19
As widespread community transmission of COVID-19 continues, researchers say the focus must shift to the broader effects on health and wellbeing, including on the mental health of children and adolescents. A recent Penn LDI study reports on the impact of the pandemic on youth at a local behavioral health hospital.
Long-term effects of COVID-19 and support to cope
Millions of people around the world have already survived a bout with COVID-19. Clinicians are learning how cases can trigger lasting consequences for the body.
The unique pandemic challenges faced by immunocompromised individuals
A photo-elicitation study funded by a Leonard Davis Institute (LDI) COVID-19 Rapid-Response grant has found that immunocompromised patients face unique challenges as a result of both their heightened risk of infection and adherence to government pandemic guidelines.
Nearly 1 in 10 COVID patients return after leaving emergency department
A new Penn study finds patients with low pulse oximetry readings or fever were more than three times as likely to require hospitalization after their initial discharge, as compared to other COVID patients.
Research Recovery Program supports scholars impacted by the pandemic
A new funding mechanism offers grants designed to help researchers mitigate unexpected costs and provides opportunities for scholars to delve into new areas of study.
Who should get the COVID-19 vaccine first?
A group of global experts led by Penn offer a model that lays the groundwork for fair distribution and prioritize reducing premature deaths.
Ensuring an ethical path to a ‘warp speed’ vaccine
Penn scholars consider the ethical implications of the development and allocation of a COVID-19 vaccine.
Cell phone location used to estimate COVID-19 growth rates
Cell phone location data shows that in counties where activity declined at workplaces and increased at home, coronavirus infection rates were lower.
Penn Medicine helps power international COVID-19 data consortium
An international consortium involving Penn researchers pools electronic health record data from around the world to discover clinical insights about COVID-19.
In the News
The mRNA miracle workers
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
Review of COVID death stats finds likely undercount in official numbers
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
The Franklin Institute honors nine scientists and engineers on its 200th anniversary
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
You should still get the COVID-19 vaccine. The Nobel Prize winner who helped discover it explains why
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
Long COVID brain fog may originate in a surprising place, say scientists
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
Long COVID research is in its ‘most hopeful’ phase yet
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →